PEPCID AC TABLET

দেশ: কানাডা

ভাষা: ইংরেজি

সূত্র: Health Canada

সক্রিয় উপাদান:

FAMOTIDINE

থেকে পাওয়া:

MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC

এটিসি কোড:

A02BA03

INN (আন্তর্জাতিক নাম):

FAMOTIDINE

ডোজ:

10MG

ফার্মাসিউটিকাল ফর্ম:

TABLET

রচনা:

FAMOTIDINE 10MG

প্রশাসন রুট:

ORAL

প্যাকেজ ইউনিট:

18/30/60

প্রেসক্রিপশন টাইপ:

OTC

থেরাপিউটিক এলাকা:

HISTAMINE H2-ANTAGONISTS

পণ্য সারাংশ:

Active ingredient group (AIG) number: 0118722003; AHFS:

অনুমোদন অবস্থা:

APPROVED

অনুমোদন তারিখ:

2011-12-02

পণ্য বৈশিষ্ট্য

_PEPCID AC_
_®_
_Page 1 of 18_
PRODUCT MONOGRAPH
PEPCID AC
®
famotidine tablets
FILM COATED TABLETS 10 MG
Mfr.
Std.
HISTAMINE H
2
RECEPTOR ANTAGONIST
McNeil Consumer Healthcare,
division of Johnson & Johnson Inc.
88 McNabb Street
Markham, Ontario
L3R 5L2
Date of Preparation:
February 14, 1996
Date of Revision:
May 24, 2019
Submission Control No: 225990
_PEPCID AC_
_®_
_Page 2 of 18_
_PEPCID AC_
_®_
_Page 3 of 18_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
.........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
....................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................3
ADVERSE REACTIONS
....................................................................................................4
DRUG INTERACTIONS
....................................................................................................5
DOSAGE AND ADMINISTRATION
................................................................................5
OVERDOSAGE
...................................................................................................................6
ACTION AND CLINICAL PHARMACOLOGY
...............................................................6
STORAGE AND STABILITY
............................................................................................8
DOSAGE FORMS, COMPOSITION AND PACKAGING
................................................8
PART II: SCIENTIFIC
INFORMATION................................................................................12
PHARMACEUTICAL INFORMATION
..........................................................................12
CLINICAL TRIALS
.......................................................